A Comparison of Visual Outcomes Between Patients Treated with Intravitreal Ranibizumab and Bevacizumab for Diabetic Macula Edema in A Real World Setting in Sub-Saharan Africa
2022Ophthalmology ResearchJournalOpen access
10.33425/2639-9482.1026Full text0 citations